June 30,

2020

December 31,

2019

Prepaid research and development expenses

1,826

1,679

Short-term deposits

1,278

1,139

Deferred financing expenses (1)(2)

1,253

2,339

Research and development tax credit receivable

522

1,036

Prepaid insurance

459

569

Value added tax receivable

302

68

Other prepaid assets

126

57

Total

$

5,766

$

6,887

(1) Deferred financing expenses as of June 30, 2020, are expenses relating to the planned rights offering and expenses relating to the June 30 SPA with a closing date of July 2, 2020 - See Note 1 for further details

(2) See Notes 8 and 9 to the condensed consolidated financial statements for further details on movements in deferred financing expenses